Uipath is trading 6.42% lower at $11.65 on September 28, 2026, amid broad risk-off sentiment following President Trump’s rejection of Iran’s proposal; no confirmed company-specific catalyst has been identified.
- Oil prices rose, renewing inflation concerns.
- Reuters reported U.S. stock futures fell and Treasury yields rose in response.
- The S&P 500, Nasdaq, and Dow were each down more than 0.5%.